THC BioMed Engages CFN Media to Support its Public Market Strategy
VANCOUVER , May 22, 2019 /CNW/ - THC BioMed Intl Ltd. ("THC", or the "Company") (THC.CN) announces that they are engaging CFN Media to conduct a 6-month investor and market visibility program beginning towards the end of May, 2019. Compensation for the public markets program will be USD $10,000 per month.
THC BioMed (CNW Group/THC BioMed)
THC BioMed (CNW Group/THC BioMed)
CFN Media will leverage its powerful content platform and extensive reach into mainstream and cannabis-focused investor audiences and media across North America to educate high-quality investors on THC's value proposition. CFN Media's program will measure investor engagement and identify interested investors via opt-in leads while elevating the Company's financial brand.
About CFN
CFN Media is the leading agency and financial media network dedicated to the cannabis industry. CFN Media helps private, pre-public and public cannabis companies in the US and Canada attract capital, investors and media attention.
CFN Media's powerful digital media and distribution platform conveys a company's message and value proposition directly to accredited and retail investors and national media active in the North American cannabis markets. www.cannabisfn.com
About THC
THC is an ACMPR Licensed Producer and Canada's largest supplier of legal Cannabis Genetics. THC is on the leading edge of scientific research and the development of products and services related to the medical cannabis industry. Management believes THC is well-positioned to be in the forefront of this rapidly growing industry. Please visit our website for a more detailed description of our business and services available. www.thcbiomed.com
